Not Tagged
arcellx
['multiple myeloma', 'cart,(-cartitude)', 'arcellx', '$aclx']
$aclx arcellx presents continued robust long-term responses from its cart-ddbcma phase 1 expansion trial in patients with relapsed or refractory multiple myeloma at the 2022 asco annual meeting 
Free Stock Market News are delayed 15 sec. Full features and live news available here: https://t.co/fWRacb3Vft